Clopidogrel alone after 1 month DAPT vs aspirin alone after 12 months DAPT in patients undergoing EES implantation: 5-year follow-up of the STOPDAPT-2 trial
A Five-year follow-up of the STOPDAPT-2 trial showed that clopidogrel alone after one month of dual antiplatelet therapy (DAPT) was non-inferior to aspirin alone after 12 months of continuous DAPT in patients who received a Xience everolimus- eluting stent (EES). Clopidogrel monotherapy after one month was also non-inferior in the evaluation of composite events of ischemia and bleeding at 5 years compared to aspirin monotherapy after 12 months of DAPT. Dr. Hirotoshi Watanabe, Hirakata kohsai Hospital, presented at the TCT WorldLink Forum session at TCT 2023.
- Free Registration
-
Already have an account?Log In
A portal site of complex catheter intervention techniques
TCROSS NEWS Global is an online medical journal that provides
valuable information on Cardiovascular medicine to medical professionals
worldwide.
We bring you the latest findings and trends in all areas of
cardiovascular medicine. Please register and subscribe for unlimited access to
quality Cardiovascular News!
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Recommendations
